Home  »  Business   »  Zai Lab Limited (NASDAQ:ZLAB) Lost -23.74% In A We...

Zai Lab Limited (NASDAQ:ZLAB) Lost -23.74% In A Week: What’s Driving The Stock?

In last trading session, Zai Lab Limited (NASDAQ:ZLAB) saw 1.01 million shares changing hands with its beta currently measuring 0.99. Company’s recent per share price level of $37.33 trading at -$5.56 or -12.96% at ring of the bell on the day assigns it a market valuation of $3.81B. That closing price of ZLAB’s stock is at a discount of -230.4% from its 52-week high price of $123.34 and is indicating a premium of 39.7% from its 52-week low price of $22.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.94 million shares which gives us an average trading volume of 559.24K if we extend that period to 3-months.

For Zai Lab Limited (ZLAB), analysts’ consensus is at an average recommendation of a Buy while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 17 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 16 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.88 in the current quarter.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Zai Lab Limited (NASDAQ:ZLAB) trade information

Upright in the red during last session for losing -12.96%, in the last five days ZLAB remained trading in the red while hitting it’s week-highest on Wednesday, 09/21/22 when the stock touched $37.33 price level, adding 24.57% to its value on the day. Zai Lab Limited’s shares saw a change of -40.60% in year-to-date performance and have moved -23.74% in past 5-day. Zai Lab Limited (NASDAQ:ZLAB) showed a performance of -11.50% in past 30-days. Number of shares sold short was 2.98 million shares which calculate 4.98 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $87.82 to the stock, which implies a rise of 57.49% to its current value. Analysts have been projecting $37.56 as a low price target for the stock while placing it at a high target of $199.00. It follows that stock’s current price would drop -433.08% in reaching the projected high whereas dropping to the targeted low would mean a loss of -0.62% for stock’s current value.

Zai Lab Limited (ZLAB) estimates and forecasts

Statistics highlight that Zai Lab Limited is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -14.81% of value to its shares in past 6 months, showing an annual growth rate of 38.92% while that of industry is 1.80. Apart from that, the company came raising its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to increase by 66.70% in the current quarter and calculating 40.90% increase in the next quarter. This year revenue growth is estimated to rise 57.10% from the last financial year’s standing.

3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $46.8 million for the same. And 4 analysts are in estimates of company making revenue of $50.87 million in the next quarter that will end on Jun 2022. Company posted $29.89 million and $36.94 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 56.60% while estimating it to be 37.70% for the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0.10% during past 5 years. In 2022, company’s earnings growth rate is likely to be around 78.10% while estimates for its earnings growth in next 5 years are of 30.00%.

ZLAB Dividends

Zai Lab Limited is more likely to be releasing its next quarterly report between February 28 and March 05 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Zai Lab Limited (NASDAQ:ZLAB)’s Major holders

Insiders are in possession of 0.09% of company’s total shares while institution are holding 73.73 percent of that, with stock having share float percentage of 73.80%. Investors also watch the number of corporate investors in a company very closely, which is 73.73% institutions for Zai Lab Limited that are currently holding shares of the company. Invesco Ltd. is the top institutional holder at ZLAB for having 8.26 million shares of worth $363.19 million. And as of Mar 30, 2022, it was holding 8.43% of the company’s outstanding shares.

The second largest institutional holder is FMR, LLC, which was holding about 4.56 million shares on Mar 30, 2022. The number of shares represents firm’s hold over 4.65% of outstanding shares, having a total worth of $200.41 million.

On the other hand, Invesco Developing Markets Fund and Fidelity Emerging Markets Fund (US) are the top two Mutual Funds which own company’s shares. As of Apr 29, 2022, the former fund manager was holding 7.24 million shares of worth $289.5 million or 7.40% of the total outstanding shares. The later fund manager was in possession of 1.3 million shares on May 30, 2022, making its stake of worth around $37.76 million in the company or a holder of 1.33% of company’s stock.

Leave a Comment

Your email address will not be published.

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]